Effect of Juzentaihoto on total hip arthroplasty: randomized controlled trial

Effects of Juzentaihoto on total hip arthroplasty: randomized controlled trial - Effects of Juzentaihoto on total hip arthroplasty

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038213

Enrollment

120

Registered

2019-10-07

Start date

2019-11-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total hip arthroplasty

Interventions

Administration of Juzentaihoto Non-administration of Juzentaihoto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who receive unilateral THA at this hospital

Exclusion criteria

Exclusion criteria: Patients allergic to Juzentaihoto

Design outcomes

Primary

Measure	Time frame
Alb change rate 4 weeks before surgery and 1, 3, 5, 7, 14 days after surgery	—

Secondary

Measure	Time frame
Hb value, infection rate, ADL improvement rate, length of hospital stay, home discharge rate, CRP value, NRS, JOA score, walking ability	—

Countries

Japan

Contacts

Public ContactMasashi Takashima

Showa University Fujigaoka Hospital Orthopedics

takashimamasashi@hotmail.co.jp0459711151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026